FIGURE 2.
Antibody [(A): OLT recipients, (B): LUT recipients] and T-cell mediated responses [(C): OLT recipients, (D): LUT recipients] to BNT162b2 vaccine against SARS-CoV-2 measured 60 days post 3rd dose in patients who experienced a breakthrough infection and those who did not, by solid organ transplantation group. BI, Breakthrough infection; INF, Interferon, LTU: Lung transplant; OLT, Orthotopic transplant; PBMC: Peripheral blood mononuclear cells; SFU: Spot forming units.